Clinical decision making in the treatment of mixed states

World Journal of Biological Psychiatry

Volumn 15, Issue 5, 2014, Pages 355-368

  Grunze, Heinz ^a   Azorin, Jean Michel ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Bipolar disorder; Clinical guidelines; Clinical management; Mixed states; Pharmacotherapy

Indexed keywords

ANTICONVULSIVE AGENT; ARIPIPRAZOLE; ASENAPINE; CARBAMAZEPINE; LITHIUM; OLANZAPINE; PALIPERIDONE; QUETIAPINE; VALPROIC ACID; ZIPRASIDONE;

ADD ON THERAPY; CLINICAL DECISION MAKING; DRUG EFFICACY; HUMAN; LICENSING; MAINTENANCE THERAPY; MIXED MANIA AND DEPRESSION; MONOTHERAPY; PHYSIOTHERAPY; PRACTICE GUIDELINE; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT RESPONSE; BIPOLAR DISORDER; DECISION MAKING;

BIPOLAR DISORDER; DECISION MAKING; HUMANS;

EID: 84904349683     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2014.908238     Document Type: Review

References (68)

1. American Psychiatric Association. 2013 Diagnostic and statistical manual of mental health disorders: DSM-5 5th ed. Washington DC: American Psychiatric Publishing
2. Azorin JM, Aubrun E, Bertsch J, Reed C, Gerard S, Lukasiewicz M. 2009. Mixed states vs pure mania in the French sample of the EMBLEM study: Results at baseline and 24 months-European mania in bipolar longitudinal evaluation of medication. BMC Psychiatry 9:33
3. Azorin JM, Sapin C, Weiller E. 2013. Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: Results from post hoc analyses. J Affect Disord 145:62-69
4. Backlund L, Ehnvall A, Hetta J, Isacsson G, Agren H. 2009. Identifying predictors for good lithium response-A retrospective analysis of 100 patients with bipolar disorder using a life-charting method. Eur Psychiatry 24:171-177
5. Baker RW, Brown E, Akiskal HS, Calabrese JR, Ketter TA, Schuh LM, et al. 2004. Effi cacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. Br J Psychiatry 185:472-478
6. Baker RW, Tohen M, Fawcett J, Risser RC, Schuh LM, Brown E, et al. 2003. Acute dysphoric mania: Treatment response to olanzapine versus placebo. J Clin Psychopharmacol 23:132-137
7. Baldessarini RJ, Hennen J, Wilson M, Calabrese J, Chengappa R, Keck PE Jr, et al. 2003. Olanzapine versus placebo in acute mania: Treatment responses in subgroups. J Clin Psychopharmacol 23:370-376
8. Benabarre A, Vieta E, Colom F, Martinez A, Reinares M, Corbella B. 2001. Treatment of mixed mania with risperidone and mood stabilizers. Can J Psychiatry 46:866-867
9. Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M. 2009. Olanzapine/fl uoxetine combination for the treatment of mixed depression in bipolar I disorder: A post hoc analysis. J Clin Psychiatry 70:1424-1431
10. Berwaerts J, Xu H, Nuamah I, Lim P, Hough D. 2012. Evaluation of the effi cacy and safety of paliperidone extended-release in the treatment of acute mania: A randomized, doubleblind, dose-response study. J Affect Disord 136:e51-e60
11. Born C, Bernhard B, Dittmann S, Seemüller F, Grunze H. 2009. Lamotrigine in bipolar disorder: Results of a mirrorimage evaluation using the NIMH Lifechart-Methodology. J Affect Disord 115:241-245
12. Bottlender R, Sato T, Kleindienst N, Strauss A, Moller HJ. 2004. Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder. J Affect Disord 78:149-152
13. Bowden CL, Collins MA, McElroy SL, Calabrese JR, Swann AC, Weisler RH, et al. 2005. Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo. Neuropsychopharmacology 30:1932-1939
14. Bowden CL, Swann AC, Calabrese JR, Rubenfaer LM, Wozniak PJ, Collins MA, et al. 2006. A randomized, placebocontrolled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry 67:1501-1510
15. Carlson BX, Ketter TA, Sun W, Timko K, McQuade RD, Sanchez R, et al. 2012. Aripiprazole in combination with lamotrigine for the long-Term treatment of patients with bipolar I disorder (manic or mixed): A randomized, multicenter, double-blind study (CN138-392). Bipolar Disord 14:41-53
16. Crismon L, Argo T, Bendele S, Suppes T. 2007. Texas Medication Algorithm Project Procedural Manual-Bipolar Disorder Algorithms. Texas Department of State Health Services. Available from: Http://www.pbhcare.org/pubdocs/upload/ documents/TIMABDman2007.pdf (accessed 18 February 2014
17. Fountoulakis KN, Kontis D, GonDa X, Siamouli M, Yatham LN. 2012. Treatment of mixed bipolar states. Int J Neuropsychopharmacol 15:1015-1026
18. Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE Jr, et al. 2009. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry 166:164-172
19. Ginsberg LD. 2006. Effi cacy and safety of lamotrigine for adults with bipolar disorder in a private practice setting. CNS Spectr 11:376-382
20. Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklowitz DJ, Marangell LB, et al. 2009. Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: Fi ndings from the STEP-BD. Am J Psychiatry 166:173-181
21. Goodwin GM. 2009. Evidence-based guidelines for treating bipolar disorder: Revised second edition-recommendations from the British Association for Psychopharmacology. J Psychopharmacol 23:346-388
22. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, et al. 2009. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania. World J Biol Psychiatry 10:85-116
23. Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA. 2009. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: A double-blind, placebo-controlled study. J Clin Psychiatry 70:1540-1547
24. Keck PE, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, et al. 2003a. A placebo-controlled, double-blind study of the effi cacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 160:1651-1658
25. Keck PE, Versiani M, Potkin S, West SA, Giller E, Ice K. 2003b. Ziprasidone in the treatment of acute bipolar mania: A three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 160:741-748
26. Kessing LV, Hellmund G, Andersen PK. 2012. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. J Psychopharmacol 26:644-652
27. Kessing LV, Hellmund G, Geddes JR, Goodwin GM, Andersen PK. 2011. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: Observational nationwide register-based cohort study. Br J Psychiatry 199:57-63
28. Khanna S, Vieta E, Lyons B, Grossman F, Eerdekens M, Kramer M. 2005. Risperidone in the treatment of acute mania: Double-blind, placebo-controlled study. Br J Psychiatry 187:229-234
29. Llorca PM, Courtet P, Martin P, Abbar M, Gay C, Meynard JA, et al. 2010. Recommandations formalisées d " experts (RFE). Dépistage et prise en charge du trouble bipolaire. Encéphale 36(Suppl)4:79-102
30. Malhi GS, Adams D, Lampe L, Paton M, O'Connor N, Newton LA, et al. 2009. Clinical practice recommendations for bipolar disorder. Acta Psychiatr Scand 119(Suppl)439:27-46
31. McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA, Panagides J. 2009a. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states. Bipolar Disord 11:673-686
32. McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA, Panagides J. 2009b. Asenapine versus olanzapine in acute mania: A doubleblind extension study. Bipolar Disord 11:815-826
33. McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA, Panagides J. 2010. Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebocontrolled trial. J Affect Disord 122:27-38
34. McIntyre RS, Tohen M, Berk M, Zhao J, Weiller E. 2013. DSM-5 mixed specifi er for manic episodes: Evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data. J Affect Disord 150:378-383
35. McIntyre RS, Yoon J. 2012. Effi cacy of antimanic treatments in mixed states. Bipolar Disord 14(Suppl)2:22-36
36. Nolen WA, Weisler RH. 2013. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: A post hoc analysis of a doubleblind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144). Bipolar Disord 15:100-109
37. Patkar A, Gilmer W, Pae CU, Vohringer PA, Ziffra M, Pirok E, et al. 2012. A 6 week randomized double-blind placebocontrolled trial of ziprasidone for the acute depressive mixed state. PLoS One 7:e34757
38. Potkin SG, Keck PE Jr, Segal S, Ice K, English P. 2005. Ziprasidone in acute bipolar mania: A 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol 25:301-310
39. Sachs G, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, et al. 2006. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: A 3-week placebo-controlled study. J Psychopharmacol 20:536-546
40. Stahl S, Lombardo I, Loebel A, Mandel FS. 2010. Effi cacy of ziprasidone in dysphoric mania: Pooled analysis of two double-blind studies. J Affect Disord 122:39-45
41. Strejilevich S, Vazquez G, Garcia BG, Zaratiegui R, Vilaprino JJ, Herbst L, et al. 2010. II Consenso argentino sobre el tratamiento De los trastornos bipolares 2010. Vertex 21(Suppl II Consenso):3-55
42. Strejilevich SA, Martino DJ, Marengo E, Igoa A, Fassi G, Whitham EA, et al. 2011. Long-Term worsening of bipolar disorder related with frequency of antidepressant exposure. Ann Clin Psychiatry 23:186-192
43. Suppes T, Eudicone J, McQuade R, Pikalov A III, Carlson B. 2008. Effi cacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder. J Affect Disord 107:145-154
44. Suppes T, Vieta E, Liu S, Brecher M, Paulsson B. 2009. Maintenance treatment for patients with bipolar I disorder: Results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry 166:476-488
45. Swann AC. 2011. Diagnosis and treatment of mixed states. In: Akiskal HS, Tohen M, eds. Bipolar psychopharmacology: Caring for the patient. West Sussex: Wiley-Blackwell. p. 391-410
46. Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J, et al. 1997. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 54:37-42
47. Swann AC, Lafer B, Perugi G, Frye MA, Bauer M, Bahk WM, et al. 2013. Bipolar mixed states: An international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry 170:31-42
48. Szegedi A, Zhao J, van WA, Nations KR, Mackle M, Panagides J. 2011. Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: A post hoc analysis of two 3-week clinical trials. BMC Psychiatry 11:101
49. Tavormina G. 2013. A long term clinical diagnostic-Therapeutic evaluation of 30 case reports of bipolar spectrum mixed states. Psychiatr Danub 25(Suppl)2:S190-193
50. Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, et al. 2006. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 163:247-256
51. Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, et al. 2002. Effi cacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 59:62-69
52. Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, et al. 2000. Effi cacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 57:841-849
53. Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, et al. 1999. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 156:702-709
54. Tohen M, Sutton VK, Calabrese JR, Sachs GS, Bowden CL. 2009. Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. J Affect Disord 116:43-50
55. Valenti M, Pacchiarotti I, Rosa AR, Bonnin CM, Popovic D, Nivoli AM, et al. 2011. Bipolar mixed episodes and antidepressants: A cohort study of bipolar I disorder patients. Bipolar Disord 13:145-154
56. Vieta E, Herraiz M, Fernandez A, Gasto C, Benabarre A, Colom F, et al. 2001. Effi cacy and safety of risperidone in the treatment of schizoaffective disorder: Initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD). J Clin Psychiatry 62:623-630
57. Vieta E, Nuamah IF, Lim P, Yuen EC, Palumbo JM, Hough DW, et al. 2010. A randomized, placebo-And active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder. Bipolar Disord 12:230-243
58. Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M. 2008. Effi cacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord 109:251-263
59. Vieta E, Suppes T, Ekholm B, Udd M, Gustafsson U. 2012. Long-Term effi cacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder. J Affect Disord 142:36-44
60. Vieta E, Valenti M. 2013. Mixed states in DSM-5: Implications for clinical care, education, and research. J Affect Disord 148:28-36
61. Weisler RH, Hirschfeld R, Cutler AJ, GazDa T, Ketter TA, Keck PE, et al. A, Kalali A. 2006. Extended-release carbamazepine capsules as monotherapy in bipolar disorder: Pooled results from two randomised, double-blind, placebocontrolled trials. CNS Drugs 20:219-231
62. Weisler RH, Kalali AH, Ketter TA. 2004. A multicenter, randomized, double-blind, placebo-controlled trial of extendedrelease carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 65:478-484
63. Weisler RH, Keck PE Jr, Swann AC, Cutler AJ, Ketter TA, Kalali AH. 2005. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: A multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 66:323-330
64. Weisler RH, Nolen WA, Neijber A, Hellqvist A, Paulsson B. 2011. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: A randomized controlled study). J Clin Psychiatry 72:1452-1464
65. Woo YS, Bahk WM, Jon DI, Chung SK, Lee SY, Ahn YM, et al. 2010. Risperidone in the treatment of mixed state bipolar patients: Results from a 24-week, multicenter, open-label study in Korea. Psychiatry Clin Neurosci 64:28-37
66. Yatham LN, Binder C, Riccardelli R, Leblanc J, Connolly M, Kusumakar V. 2003. Risperidone in acute and continuation treatment of mania. Int Clin Psychopharmacol 18:227-235
67. Yatham LN, Fountoulakis KN, Rahman Z, Ammerman D, Fyans P, Marler SV, et al. 2013a. Effi cacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratifi ed by index manic or mixed episode. J Affect Disord 147:365-372
68. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, AlDa M, et al. 2013b. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2013. Bipolar Disord 15:1-44.